Clinical Trial Update: Monotherapy With Levetiracetam in Newly Diagnosed Patients Suffering From Epilepsy [Phase 3]

View source ↗

Summary

A Phase 3 trial of levetiracetam monotherapy in newly diagnosed patients with generalized epilepsy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Generalized Epilepsy

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: UCB Pharma | Conditions: Generalized Epilepsy | Phase 3 | Status: COMPLETED